HealthLeaders Media April 27, 2022
Ana Mulero

The bills aim to speed the discovery of new cures, improve patient representation in clinical trials, and enhance the FDA’s ability to ensure safety, efficacy, and quality of the drug supply.

KEY TAKEAWAYS

– A House subcommittee is taking up 22 bills that tackle different areas in healthcare, particularly in pharma, that need major legislative change.

– The mostly bipartisan bills aim to speed the discovery of new cures, improve patient representation in clinical trials and enhance the FDA’s ability to fulfill its mission of ensuring the safety, efficacy, and quality of the drug supply.

– Industry trade associations BIO, PhRMA, and the Association for Accessible Medicines (AAM) each provided testimony during the recent hearing in support of certain...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Congress / White House, FDA, Govt Agencies, Pharma, Pharma / Biotech, Regulations
Brazil’s plan for low-cost CAR-Ts
PacBio’s Repeat Expansion Panel, Owkin-Sanofi AI Take on Immunology, More
STAT+: Borrowing an idea from cancer immunotherapy, scientists make old-mice immune systems youthful again
Moderna gets Blackstone backing for flu vaccine R&D
FDA Approves Winrevair, Merck’s Novel Treatment for Pulmonary Arterial Hypertension

Share This Article